JP2018199675A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018199675A5 JP2018199675A5 JP2018111785A JP2018111785A JP2018199675A5 JP 2018199675 A5 JP2018199675 A5 JP 2018199675A5 JP 2018111785 A JP2018111785 A JP 2018111785A JP 2018111785 A JP2018111785 A JP 2018111785A JP 2018199675 A5 JP2018199675 A5 JP 2018199675A5
- Authority
- JP
- Japan
- Prior art keywords
- configuration
- amount
- cancer stem
- stem cells
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261612826P | 2012-03-19 | 2012-03-19 | |
| US61/612,826 | 2012-03-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501847A Division JP6502247B2 (ja) | 2012-03-19 | 2013-03-19 | 癌の状態を治療及びモニタリングする方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020101337A Division JP2020158518A (ja) | 2012-03-19 | 2020-06-11 | 癌の状態を治療及びモニタリングする方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018199675A JP2018199675A (ja) | 2018-12-20 |
| JP2018199675A5 true JP2018199675A5 (https=) | 2019-02-07 |
Family
ID=49223299
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501847A Active JP6502247B2 (ja) | 2012-03-19 | 2013-03-19 | 癌の状態を治療及びモニタリングする方法 |
| JP2018111785A Pending JP2018199675A (ja) | 2012-03-19 | 2018-06-12 | 癌の状態を治療及びモニタリングする方法 |
| JP2020101337A Pending JP2020158518A (ja) | 2012-03-19 | 2020-06-11 | 癌の状態を治療及びモニタリングする方法 |
| JP2021213614A Pending JP2022058444A (ja) | 2012-03-19 | 2021-12-28 | 癌の状態を治療及びモニタリングする方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501847A Active JP6502247B2 (ja) | 2012-03-19 | 2013-03-19 | 癌の状態を治療及びモニタリングする方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020101337A Pending JP2020158518A (ja) | 2012-03-19 | 2020-06-11 | 癌の状態を治療及びモニタリングする方法 |
| JP2021213614A Pending JP2022058444A (ja) | 2012-03-19 | 2021-12-28 | 癌の状態を治療及びモニタリングする方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20150079135A1 (https=) |
| EP (4) | EP3855184B1 (https=) |
| JP (4) | JP6502247B2 (https=) |
| CA (2) | CA3223380A1 (https=) |
| ES (3) | ES2973957T3 (https=) |
| WO (1) | WO2013142477A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102622188B1 (ko) | 2016-10-07 | 2024-01-05 | 엔터롬 에스.에이. | 암 치료를 위한 면역원성 화합물 |
| WO2018065628A2 (en) | 2016-10-07 | 2018-04-12 | Enterome | Microbiota sequence variants of tumor-related antigenic epitopes |
| US11478538B2 (en) | 2016-10-07 | 2022-10-25 | Enterome S.A. | Immunogenic compounds for cancer therapy |
| CN112118863B (zh) | 2018-04-11 | 2025-05-30 | 恩特罗姆公司 | 用于预防和治疗癌症的抗原肽 |
| EP3773673A2 (en) * | 2018-04-11 | 2021-02-17 | Enterome S.A. | Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation |
| GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| DE4121547A1 (de) | 1991-06-28 | 1993-01-14 | Daimler Benz Ag | Mehrschichtisolierfolie |
| HK1006056A1 (en) | 1991-10-07 | 1999-02-05 | Astellas Us Llc | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
| US6162432A (en) | 1991-10-07 | 2000-12-19 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
| US5441050A (en) | 1992-12-18 | 1995-08-15 | Neoprobe Corporation | Radiation responsive surgical instrument |
| EP1372720A4 (en) | 2001-03-02 | 2006-07-26 | Medimmune Inc | PREVENTING OR TREATING INFLAMMATORY OR AUTOIMMUNE DISORDERS BY ADMINISTERING ANTAGONISTS OF INTEGRIN ALPHA V BETA 3 |
| WO2002098370A2 (en) | 2001-03-02 | 2002-12-12 | Medimmune, Inc. | Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| FR2838742B1 (fr) * | 2002-04-23 | 2004-07-09 | Inst Nat Sante Rech Med | Epitopes t de l'antigene epha2 |
| JP4764818B2 (ja) | 2003-04-11 | 2011-09-07 | メディミューン，エルエルシー | 組換えｉｌ−９抗体およびその使用 |
| JP5129149B2 (ja) * | 2005-10-31 | 2013-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 癌を処置および診断するための組成物および方法 |
| US8343461B2 (en) * | 2006-03-08 | 2013-01-01 | Wake Forest University Health Sciences | Molecular signature of cancer |
| CA2646539A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
| CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| WO2008030616A2 (en) * | 2006-09-07 | 2008-03-13 | Stemline Therapeutics, Inc. | Monitoring cancer stem cells |
| WO2008030538A2 (en) * | 2006-09-07 | 2008-03-13 | Stemline Therapeutics, Inc. | Cancer stem cell-targeted cancer therapy |
| KR101523698B1 (ko) * | 2007-01-22 | 2015-05-29 | 마크로제닉스 웨스트 인코퍼레이티드 | 사람 암 줄기세포 |
| JP2010190572A (ja) * | 2007-06-01 | 2010-09-02 | Sapporo Medical Univ | ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬 |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| EP2608799B1 (en) * | 2010-08-24 | 2018-12-12 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
-
2013
- 2013-03-19 CA CA3223380A patent/CA3223380A1/en active Pending
- 2013-03-19 WO PCT/US2013/032936 patent/WO2013142477A1/en not_active Ceased
- 2013-03-19 EP EP20211725.5A patent/EP3855184B1/en active Active
- 2013-03-19 EP EP23210443.0A patent/EP4361634A3/en not_active Withdrawn
- 2013-03-19 ES ES20211725T patent/ES2973957T3/es active Active
- 2013-03-19 ES ES13763504T patent/ES2699817T3/es active Active
- 2013-03-19 EP EP13763504.1A patent/EP2828664B1/en active Active
- 2013-03-19 JP JP2015501847A patent/JP6502247B2/ja active Active
- 2013-03-19 US US14/386,242 patent/US20150079135A1/en not_active Abandoned
- 2013-03-19 EP EP18189485.8A patent/EP3431997B1/en active Active
- 2013-03-19 ES ES18189485T patent/ES2887580T3/es active Active
- 2013-03-19 CA CA2902415A patent/CA2902415C/en active Active
-
2018
- 2018-02-12 US US15/894,121 patent/US20190031772A1/en not_active Abandoned
- 2018-06-12 JP JP2018111785A patent/JP2018199675A/ja active Pending
-
2020
- 2020-06-11 JP JP2020101337A patent/JP2020158518A/ja active Pending
-
2021
- 2021-12-28 JP JP2021213614A patent/JP2022058444A/ja active Pending
-
2022
- 2022-08-04 US US17/881,007 patent/US20230374152A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018199675A5 (https=) | ||
| JP6672383B2 (ja) | 間葉及び上皮間葉形質転換循環腫瘍細胞のための特異的検出ツール | |
| JP2020169198A (ja) | 治療方法及び組成物 | |
| KR102311590B1 (ko) | 신장 질환 및 치주 질환의 검출 및 진단을 위한 방법 및 조성물 | |
| CN107249636B (zh) | 以ckap4作为靶分子的抗肿瘤剂 | |
| EP2971047A1 (en) | Monoclonal antibodies to transferrin and transferrin receptor antigens, and uses thereof | |
| US7744882B2 (en) | Soluble ErbB3 methods of detection and antibodies | |
| AU2010268979B2 (en) | New tumor marker | |
| WO2019065747A1 (ja) | 抗ｃｋａｐ４モノクローナル抗体 | |
| CN105393121B (zh) | 诊断癌症的方法 | |
| CN1862258A (zh) | 核仁素辅助的癌症诊断与治疗方法 | |
| CN111378040B (zh) | 检测多种恶性肿瘤细胞的抗体及其应用 | |
| EP1956032B1 (en) | Monoclonal antibody directed against cd166 and method for production thereof | |
| AU2005219322B2 (en) | Pharmaceutical Composition Comprising CXCR3 Inhibitor | |
| JP2004509357A (ja) | 予後インジケーター | |
| US8389684B2 (en) | Tumor biomarker | |
| EP2484693A1 (en) | Human serum amyloid-a3 antibody and use thereof | |
| US7745398B2 (en) | Soluble ErbB3 and treatment of cancer | |
| JP6729917B2 (ja) | ＥｐｈＡ２ Ｎ末端フラグメント抗体 | |
| JP7416445B2 (ja) | ブタにおけるｔ細胞の活性化度を評価する方法、ブタにおけるｔ細胞活性化を評価する剤、ブタｔ細胞活性化剤をスクリーニングする方法、ブタの病原体感染を検査する方法、及びハイブリドーマ | |
| WO2008066483A1 (en) | Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders | |
| WO2012133994A1 (ko) | Pauf 및 그의 결합 파트너를 상호작용을 이용한 암 치료제의 스크리닝 방법 | |
| AU2014203702B2 (en) | New tumor marker | |
| CA2714880C (en) | A novel tumor biomarker | |
| KR20210097690A (ko) | 암 치료용 펩티드 치료법 및 이의 용도 |